Two-phase homogeneous diffusion model for the fixed bed sorption of heavy metals on natural zeolites

In this work, the fixed bed removal kinetics of Pb2+, Zn2+, Mn2+, Cr3+, Fe3+ and Cu2+ from aqueous solutions on natural zeolites was studied. For this aim, a non-dimensional two-phase homogeneous solid diffusion model including axial dispersion and equipped with a universal double-selectivity equilibrium model is developed and applied. In total 9 isotherms, representing 128 experimental points and 25 breakthrough curves, representing 764 experimental points are used in modeling. The application of the model is satisfactory resulted in an average deviation from the experimental data of 11.19 ± 5.53%. The solid phase diffusion coefficients are between 10−7 and 10−9 cm2/s depending on the metal, flow rate and particle size in the decreasing order of Cu > Fe, Cr > Zn, Pb > Mn. The study is supplemented by an extended literature review on fixed bed models and experimentally derived solid phase diffusion coefficients in zeolites

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges.

Introduction: Tuberculosis (TB) remains a major health threat and it is now clear that the current vaccine, BCG, is unable to arrest the global TB epidemic. A new vaccine is needed to either replace or boost BCG so that a better level of protection could be achieved. The route of entry of Mycobacterium tuberculosis, the causative organism, is via inhalation making TB primarily a respiratory disease. There is therefore good reason to hypothesize that a mucosally delivered vaccine against TB could be more effective than one delivered via the systemic route.Areas covered: This review summarizes the progress that has been made in the area of TB mucosal vaccines in the last few years. It highlights some of the strengths and shortcomings of the published evidence and aims to discuss immunological and practical considerations in the development of mucosal vaccines.Expert opinion: There is a growing body of evidence that the mucosal approach to vaccination against TB is feasible and should be pursued. However, further key studies are necessary to both improve our understanding of the protective immune mechanisms operating in the mucosa and the technical aspects of aerosolized delivery, before such a vaccine could become a feasible, deployable strategy

Sustainable treatment method of a high concentrated NH3 wastewater by using natural zeolite in closed-loop fixed bed systems

The aim of this study is to investigate ammonium removal from a wastewater resulted after homogenization and anaerobic digestion of a mixture of wastes and wastewater from animal processing units and sewage sludge, by using natural zeolite clinoptilolite. Batches as well as closed loop fixed bed system (CLFB) are studied, offering an alternative to conventional fixed bed systems. The experimental results showed that the optimum pH is in the vicinity of 6.48, where the achieved removal in the batch system reached 46%. The CLFB system, under the same experimental conditions and relative flow rate of 2.56 BV h−1, reached a removal of 55%, which is almost 22% higher. In the CLFB the removal of ammonia could be further increased by diluting the initial solution by 1/8, reaching the level of 96%. The achieved zeolite loading, for all studied systems, is between 2.62 and 13 mg g−1. This kind of operation is very useful for relatively high concentration and small volumes of wastewater and in systems that there is no need for continuous flow operation

Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation

SummaryObjectiveTo assess whether tumor necrosis factor (TNF) antagonism can attenuate eosinophilic airway inflammation in patients with mild-to-moderate allergic asthma.DesignRandomized, double-blind, placebo-controlled trial.SettingNational Institutes of Health (NIH) Clinical Center.PatientsTwenty-six patients with mild-to-moderate allergic asthma, receiving only inhaled β-2-agonists, who demonstrated both an early and late phase response to inhalational allergen challenge.InterventionInjection of a soluble TNF receptor (TNFR:Fc, etanercept, Enbrel) or placebo, 25mg subcutaneously, twice weekly for 2 weeks, followed by a bronchoscopic segmental allergen challenge.MeasurementsThe primary outcome measure was whether TNFR:Fc can access the lung and inhibit TNF bioactivity. Secondary outcome measures included pulmonary eosinophilia, Th2-type cytokines, and airway hyperresponsiveness.ResultsAnti-TNF therapy was associated with transient hemiplegia in one patient, which resulted in suspension of the study. Data from the 21 participants who completed the study were analyzed. Following treatment, patients receiving anti-TNF therapy had significantly increased TNFR2 levels in epithelial lining fluid (ELF) (P<0.001), consistent with delivery of TNFR:Fc to the lung. TNF antagonism did not attenuate pulmonary eosinophilia and was associated with an increase in ELF IL-4 levels (P=0.033) at 24h following segmental allergen challenge. TNF antagonism was not associated with a change in airway hyperresponsiveness to methacholine.ConclusionsTNF antagonism may not be effective for preventing allergen-mediated eosinophilic airway inflammation in mild-to-moderate asthmatics. Transient hemiplegia, which may mimic an evolving stroke, may be a potential toxicity of anti-TNF therapy

Selective CO₂ capture in metal-organic frameworks with azine-functionalized pores generated by mechanosynthesis

Two new three-dimensional porous Zn(II)-based metal-organic frameworks, containing azine-functionalized pores, have been readily and quickly isolated via mechanosynthesis, by using a nonlinear dicarboxylate and linear N-donor ligands. The use of nonfunctionalized and methyl-functionalized N-donor ligands has led to the formation of frameworks with different topologies and metal-ligand connectivities and therefore different pore sizes and accessible volumes. Despite this, both metal-organic frameworks (MOFs) possess comparable BET surface areas and CO₂ uptakes at 273 and 298 K at 1 bar. The network with narrow and interconnected pores in three dimensions shows greater affinity for CO compared to the network with one-dimensional and relatively large pores-attributable to the more effective interactions with the azine groups

Genetical genomics: spotlight on QTL hotspots

No abstract available

A LOFAR prompt search for radio emission accompanying X-ray flares in GRB 210112A

© The Author(s) 2023. Published by Oxford University Press on behalf of Royal Astronomical Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/).The composition of relativistic gamma-ray burst (GRB) jets and their emission mechanisms are still debated, and they could be matter or magnetically dominated. One way to distinguish these mechanisms arises because a Poynting flux dominated jet may produce low-frequency radio emission during the energetic prompt phase, through magnetic reconnection at the shock front. We present a search for radio emission coincident with three GRB X-ray flares with the LOw Frequency ARray (LOFAR), in a rapid response mode follow-up of long GRB 210112A (at z~2) with a 2 hour duration, where our observations began 511 seconds after the initial swift-BAT trigger. Using timesliced imaging at 120-168 MHz, we obtain upper limits at 3 sigma confidence of 42 mJy averaging over 320 second snapshot images, and 87 mJy averaging over 60 second snapshot images. LOFAR's fast response time means that all three potential radio counterparts to X-ray flares are observable after accounting for dispersion at the estimated source redshift. Furthermore, the radio pulse in the magnetic wind model was expected to be detectable at our observing frequency and flux density limits which allows us to disfavour a region of parameter space for this GRB. However, we note that stricter constraints on redshift and the fraction of energy in the magnetic field are required to further test jet characteristics across the GRB population.Peer reviewe

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.

The development of a functional biomarker assay in the tuberculosis (TB) field would be widely recognized as a major advance in efforts to develop and to test novel TB vaccine candidates efficiently. We present preliminary studies using mycobacterial growth inhibition assays (MGIAs) to detect Mycobacterium bovis BCG vaccine responses across species, and we extend this work to determine whether a standardized MGIA can be applied in characterizing new TB vaccines. The comparative MGIA studies reviewed here aimed to evaluate robustness, reproducibility, and ability to reflect in vivo responses. In doing so, they have laid the foundation for the development of a MGIA that can be standardized and potentially qualified. A major challenge ahead lies in better understanding the relationships between in vivo protection, in vitro growth inhibition, and the immune mechanisms involved. The final outcome would be a MGIA that could be used with confidence in TB vaccine trials. We summarize data arising from this project, present a strategy to meet the goals of developing a functional assay for TB vaccine testing, and describe some of the challenges encountered in performing and transferring such assays

Atenolol versus losartan in children and young adults with Marfan's syndrome

BACKGROUND : Aortic-root dissection is the leading cause of death in Marfan's syndrome. Studies suggest that with regard to slowing aortic-root enlargement, losartan may be more effective than beta-blockers, the current standard therapy in most centers. METHODS : We conducted a randomized trial comparing losartan with atenolol in children and young adults with Marfan's syndrome. The primary outcome was the rate of aortic-root enlargement, expressed as the change in the maximum aortic-root-diameter z score indexed to body-surface area (hereafter, aortic-root z score) over a 3-year period. Secondary outcomes included the rate of change in the absolute diameter of the aortic root; the rate of change in aortic regurgitation; the time to aortic dissection, aortic-root surgery, or death; somatic growth; and the incidence of adverse events. RESULTS : From January 2007 through February 2011, a total of 21 clinical centers enrolled 608 participants, 6 months to 25 years of age (mean [+/- SD] age, 11.5 +/- 6.5 years in the atenolol group and 11.0 +/- 6.2 years in the losartan group), who had an aorticroot z score greater than 3.0. The baseline-adjusted rate of change (+/- SE) in the aortic-root z score did not differ significantly between the atenolol group and the losartan group (-0.139 +/- 0.013 and -0.107 +/- 0.013 standard-deviation units per year, respectively; P = 0.08). Both slopes were significantly less than zero, indicating a decrease in the degree of aortic-root dilatation relative to body-surface area with either treatment. The 3-year rates of aortic-root surgery, aortic dissection, death, and a composite of these events did not differ significantly between the two treatment groups. CONCLUSIONS : Among children and young adults with Marfan's syndrome who were randomly assigned to losartan or atenolol, we found no significant difference in the rate of aorticroot dilatation between the two treatment groups over a 3-year period

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.

The current vaccine against tuberculosis, live attenuated Mycobacterium bovis BCG, has variable efficacy, but development of an effective alternative is severely hampered by the lack of an immune correlate of protection. There has been a recent resurgence of interest in functional in vitro mycobacterial growth inhibition assays (MGIAs), which provide a measure of a range of different immune mechanisms and their interactions. We identified a positive correlation between mean corpuscular haemoglobin and in vitro growth of BCG in whole blood from healthy UK human volunteers. Mycobacterial growth in peripheral blood mononuclear cells (PBMC) from both humans and macaques was increased following the experimental addition of haemoglobin (Hb) or ferric iron, and reduced following addition of the iron chelator deferoxamine (DFO). Expression of Hb genes correlated positively with mycobacterial growth in whole blood from UK/Asian adults and, to a lesser extent, in PBMC from South African infants. Taken together our data indicate an association between Hb/iron levels and BCG growth in vitro, which may in part explain differences in findings between whole blood and PBMC MGIAs and should be considered when using such assays